Savant Capital’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$448K Buy
49,993
+17,573
+54% +$157K ﹤0.01% 1158
2025
Q1
$243K Buy
32,420
+21,835
+206% +$164K ﹤0.01% 1325
2024
Q4
$79.6K Sell
10,585
-11,477
-52% -$86.3K ﹤0.01% 1384
2024
Q3
$168K Buy
+22,062
New +$168K ﹤0.01% 1299